Small Cell Lung Cancer Clinical Trials

Tucson : Arizona Cancer Center @ UMC North Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Los Angeles : UCLA Oncology Center Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Orange : St. Joseph's Hospital Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Pasadena : UCLA Hematology Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Santa Monica : UCLA Oncology Clinic Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Valencia : UCLA Santa Clarita Valley Cancer Center Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

View More »

Westlake Village : UCLA Oncology Center Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

New Haven : Yale Medical Center Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Washington : Sibley Memorial Hospital Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Fort Lauderdale : Holy Cross Hospital

CALGB 30610

Fort Lauderdale : Holy Cross Hospital

IMGN 901 NORTH

View More »

Fort Lauderdale : Holy Cross Hospital Bienes Comprehensive Cancer Center Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Gainesville : University of Florida Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Miami : VA. Medical Center

Trial of pasireotideLAR and Topotecan in Relapsed or Refractory Small Cell Lung Cancer

Elk Grove Village : Alexian Brothers Hospital Network

A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (> 4 cm) - IIIA Non-Small Cell Lung Cancer (NSCLC).

Elk Grove Village : Alexian Brothers Hospital Network

E1508 A Randomized Phase II Study of Cisplatin and Etoposide In Combination with Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients with Extensive Stage Small Cell Lung Cancer

Annapolis : Anne Arundel Medical Center Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Baltimore : Johns Hopkins University Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Baltimore : Greater Baltimore Medical Center Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Baltimore : Bayview Medical Center Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Boston : GSK Investigational Site

A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers

Boston : Massachusetts General Hospital Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Boston : Dana Farber Cancer Institute Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Boston : Beth Israel Deaconess Medical Center Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Detroit : Barbara Ann Karmanos Cancer Institute Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Hackensack : Johnson Therurer Cancer Center at Hackensack Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Cleveland : University Hospitals of Cleveland Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Oklahoma City : Oklahoma University Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Portland : Oregon Health and Science University Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Philadelphia : GSK Investigational Site

A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers

Philadelphia : Investigational Site Number 840101 Updated

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Pittsburgh : Univeristy of Pittsburg Medical Center Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Columbia : South Carolina Oncology Associates Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Knoxville : University of Tennessee Medical Center Cancer Institute Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Nashville : Sarah Cannon Research Institute Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

San Antonio : UTHSC at San Antonio Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Salt Lake City : Investigational Site Number 840004 Updated

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Tacoma : Northwest Medical Specialties Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Hamilton : Juravinski Cancer Center Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Montreal : St. Mary's Hospital Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Montreal : Montreal General Hospital Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Montreal : Royal Victoria Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Montreal : Jewish General Hospital Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

View More »

Toronto : Investigational Site Number 124001 Updated

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Santiago : Investigational Site Number 152003 Updated

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Angers : Centre Hospitalier Universitaire

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Bastia : Site 05

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Beauvais : Site 22

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Brest : Centre Hospitalier du Morvan

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Caen : Centre François Baclesse

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

View More »

Caen : Site 43

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Cergy-pontoise : Centre Hospitalier René Dubos

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Creteil : Site 33

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Draguignan : Site 07

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Elbeuf : Site 32

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

GAP : Site 04

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

La Roche Sur Yon : Centre Hospitalier Les Oudairies

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Limoges : Hospital du Cluzeau

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Longjumeau : Centre Hospitalier Régional

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Lyon : Centre Hospitalier Lyon Sud

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Mantes La Jolie : Site 25

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Marseille : Site 06

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Martigues : Site 27

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Meaux : Site 01

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Paris : Hospital Saint Antoine

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Rouen : Site 17

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Saint Brieuc : Hôpital Yves Le Foll

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Toulon : Site 14

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Toulouse : Investigational Site Number 250001 Updated

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Villefranche Sur Saone : Site 11

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Berlin : Hematology & Oncology Charité CBF Berlin, Germany

A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage

Großhansdorf : Investigational Site Number 276003 Updated

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Kassel : Investigational Site Number 276001 Updated

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Löwenstein : Investigational Site Number 276006 Updated

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Monza : Investigational Site Number 380003 Updated

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Daegu : Chungbuk University Hospital

Study to Assess of Belotecan or Topotecan on Daily Schedule in Relapsed Small Cell Lung Cancer (SCLC) Patients

Daegu : Keimyung University Dongsan Center

Study to Assess of Belotecan or Topotecan on Daily Schedule in Relapsed Small Cell Lung Cancer (SCLC) Patients

Goyang : National Cancer Center.

Study to Assess of Belotecan or Topotecan on Daily Schedule in Relapsed Small Cell Lung Cancer (SCLC) Patients

Goyang-si : National Cancer Center, Korea

Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy

Hwasun-gun, Jeonnam : Chonnam National University Hwasun Hospital

Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient

View More »

Seoul : Seoul St. Mary's Hospital

Study to Assess of Belotecan or Topotecan on Daily Schedule in Relapsed Small Cell Lung Cancer (SCLC) Patients

Seoul : Severance Hospital

Study to Assess of Belotecan or Topotecan on Daily Schedule in Relapsed Small Cell Lung Cancer (SCLC) Patients

Seoul : Seoul National University Hospital

Study to Assess of Belotecan or Topotecan on Daily Schedule in Relapsed Small Cell Lung Cancer (SCLC) Patients

Seoul : Asan Medical Center

Study to Assess of Belotecan or Topotecan on Daily Schedule in Relapsed Small Cell Lung Cancer (SCLC) Patients

Suwon : St. Vincent's Hospital

Study to Assess of Belotecan or Topotecan on Daily Schedule in Relapsed Small Cell Lung Cancer (SCLC) Patients

Suwon : Ajou University Hospital

Study to Assess of Belotecan or Topotecan on Daily Schedule in Relapsed Small Cell Lung Cancer (SCLC) Patients

Barcelona : Hospital Vall d'Hebron Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Barcelona : Hospital de la Santa Creu y Sand Pau Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Madrid : Hospital Universitario 12 de Octubre Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Madrid : Hospital Universitario Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Sabadell : Corporacio Sanitaria Parc Tauli Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

View More »

Sevilla : Hospital Universitario Virgen del Rocio Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Gävle : Gävle hospital

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Göteborg : Sahlgrenska University Hospital

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Helsingborg : Helsingborg Hospital

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Jönköping : Ryhov Hospital, Jönköping

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Karlskrona : Blekinge Hospital

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

View More »

Karlstad : Central Hospital

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Kristianstad : Central Hospital

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Linköping : University Hospital Linköping

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Lund : University Hospital Department of Respiratory Medicine

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Malmö : University Hospital MAS

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Örebro : University Hospital, Örebro

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Stockholm : Karolinska University Hospital

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Umeå : Norrlands University Hospital

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Uppsala : Akademiska hospital Uppsala

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Växjö : Central Hospital

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Ystad : Ystad hospital

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

Brighton : Royal Sussex Hospital Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Cambridge : Cambridge University Hospitals NHS Foundation Trust

HYPAZ: Hypertension Induced by Pazopanib

Downs Road : Royal Marsden, Sutton Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

London : University College of London Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

London : Royal Marsden, London Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

View More »

Southampton : Southampton University Hospitals NHS Trust

The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer

Withington : The Christie Hospital Updated

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer